JUN TERUYA to Recombinant Proteins
This is a "connection" page, showing publications JUN TERUYA has written about Recombinant Proteins.
Connection Strength
0.569
-
Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study. Pediatr Crit Care Med. 2022 10 01; 23(10):e465-e475.
Score: 0.155
-
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods. Int J Lab Hematol. 2022 Jun; 44(3):589-594.
Score: 0.150
-
Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing. Thromb Res. 2020 02; 186:54-57.
Score: 0.130
-
Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Arch Pathol Lab Med. 2014 Sep; 138(9):1229-32.
Score: 0.090
-
Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2024 Feb; 38(2):388-393.
Score: 0.043